|Bid||649.66 x 800|
|Ask||650.88 x 800|
|Day's range||636.93 - 652.40|
|52-week range||419.12 - 706.95|
|Beta (5Y monthly)||0.93|
|PE ratio (TTM)||83.50|
|Earnings date||27 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||717.50|
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Strong organic recurring revenue growth in CAG diagnostics business and the recent ezyVet buyout are likely to have contributed to growth for IDEXX (IDXX).
Idexx Laboratories (IDXX) closed the most recent trading day at $651.96, moving -0.09% from the previous trading session.